Recently, the office of the national medical security administration and the medical treatment team of the joint prevention and control mechanism of the State Council for novel coronavirus pneumonia jointly issued the notice on further reducing the price of novel coronavirus nucleic acid detection and antigen detection (hereinafter referred to as the notice). In response to the problems such as the cost of nucleic acid detection of novel coronavirus, which is more concerned by public opinion, the person in charge of the relevant department of the National Medical Insurance Bureau accepted an interview with the reporter. The person in charge said that carrying out normalized nucleic acid detection can timely find the source of infection of COVID-19 virus, quickly lock the control target and effectively cut off the transmission route. It is an effective means to implement the general policy of "dynamic clearing". In order to combat the COVID-19, the National Medical Insurance Bureau earnestly performed the price management function of medical consumables, deployed medical insurance departments at all levels to take measures such as centralized procurement through inter provincial alliance, bidding and network connection, and regional price linkage, and continued to lead the prices of test products into a lower range; The majority of testing institutions also continue to optimize the work of mining, transportation and inspection, and continue to reduce costs and increase efficiency. On this basis, the price of nucleic acid detection of novel coronavirus has been reduced for several consecutive rounds, continuously reducing the cost of epidemic prevention and control. According to the notice, before June 10, all localities will reduce the single person detection of novel coronavirus nucleic acid to no more than 16 yuan per person, and the multi person mixed detection to no more than 5 yuan per person. For the large-scale screening and normalized testing organized by the government, the testing institutions are required to provide services according to the mixed testing of multiple people, which is no more than 3.5 yuan per person. In addition, the cost of nucleic acid detection incurred by insured patients when they see a doctor can be paid by the medical insurance fund according to regulations. These measures provide strong support for the general policy of "dynamic clearing" and fully ensure the overall situation of epidemic prevention and control. The person in charge introduced that the cost of normalized nucleic acid detection, which has been paid great attention by online public opinion recently, shall be borne by local governments in accordance with the guiding opinions of the State Council on doing a good job in the normalized prevention and control of the novel coronavirus infected pneumonia epidemic through the joint prevention and control mechanism of the State Council and the opinions on accelerating the implementation of novel coronavirus nucleic acid detection. Therefore, at present, financial departments have provided financial support for normalized nucleic acid detection. (outlook new era)